These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 20974180)

  • 1. Non-structural protein 1 (NS1) antibody-based assays to differentiate West Nile (WN) virus from Japanese encephalitis virus infections in horses: effects of WN virus NS1 antibodies induced by inactivated WN vaccine.
    Kitai Y; Kondo T; Konishi E
    J Virol Methods; 2011 Jan; 171(1):123-8. PubMed ID: 20974180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope-blocking enzyme-linked immunosorbent assay to differentiate west nile virus from Japanese encephalitis virus infections in equine sera.
    Kitai Y; Shoda M; Kondo T; Konishi E
    Clin Vaccine Immunol; 2007 Aug; 14(8):1024-31. PubMed ID: 17596430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific antibody responses to West Nile virus infections in horses preimmunized with inactivated Japanese encephalitis vaccine: evaluation of blocking enzyme-linked immunosorbent assay and complement-dependent cytotoxicity assay.
    Kitai Y; Shirafuji H; Kanehira K; Kamio T; Kondo T; Konishi E
    Vector Borne Zoonotic Dis; 2011 Aug; 11(8):1093-8. PubMed ID: 21254919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-dependent cytotoxicity assay for differentiating West Nile virus from Japanese encephalitis virus infections in horses.
    Kitai Y; Kondo T; Konishi E
    Clin Vaccine Immunol; 2010 May; 17(5):875-8. PubMed ID: 20237201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation of an enzyme-linked immunosorbent assay for quantifying antibodies to Japanese encephalitis virus nonstructural 1 protein to detect subclinical infections in vaccinated horses.
    Konishi E; Shoda M; Ajiro N; Kondo T
    J Clin Microbiol; 2004 Nov; 42(11):5087-93. PubMed ID: 15528700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
    El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of an Algorithm Using prM/E- and NS1-Specific IgM Antibody-Capture Enzyme-Linked Immunosorbent Assays in Diagnosis of Japanese Encephalitis Virus and West Nile Virus Infections in Humans.
    Galula JU; Chang GJ; Chuang ST; Chao DY
    J Clin Microbiol; 2016 Feb; 54(2):412-22. PubMed ID: 26659204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of an attenuated West Nile virus vaccine, live Flavivirus chimera in horses.
    Long MT; Gibbs EP; Mellencamp MW; Zhang S; Barnett DC; Seino KK; Beachboard SE; Humphrey PP
    Equine Vet J; 2007 Nov; 39(6):486-90. PubMed ID: 18065304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacies of three commercially available vaccines against West Nile Virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model.
    Seino KK; Long MT; Gibbs EP; Bowen RA; Beachboard SE; Humphrey PP; Dixon MA; Bourgeois MA
    Clin Vaccine Immunol; 2007 Nov; 14(11):1465-71. PubMed ID: 17687109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.
    Long MT; Gibbs EP; Mellencamp MW; Bowen RA; Seino KK; Zhang S; Beachboard SE; Humphrey PP
    Equine Vet J; 2007 Nov; 39(6):491-7. PubMed ID: 18065305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine.
    Lim CK; Takasaki T; Kotaki A; Kurane I
    Virology; 2008 Apr; 374(1):60-70. PubMed ID: 18221765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonstructural protein 1 antibody-based epitope-blocking enzyme-linked immunosorbent assay to differentiate Japanese encephalitis virus from dengue virus infections in humans.
    Konishi E; Konishi M
    Jpn J Infect Dis; 2011; 64(4):284-91. PubMed ID: 21788702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anamnestic serologic response to vaccination with a canarypox virus-vectored recombinant West Nile virus (WNV) vaccine in horses previously vaccinated with an inactivated WNV vaccine.
    Grosenbaugh DA; Backus CS; Karaca K; Minke JM; Nordgren RM
    Vet Ther; 2004; 5(4):251-7. PubMed ID: 15719324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equine vaccine for West Nile virus.
    Ng T; Hathaway D; Jennings N; Champ D; Chiang YW; Chu HJ
    Dev Biol (Basel); 2003; 114():221-7. PubMed ID: 14677692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Serological Protein Microarray for Detection of Multiple Cross-Reactive Flavivirus Infections in Horses for Veterinary and Public Health Surveillance.
    Cleton NB; van Maanen K; Bergervoet SA; Bon N; Beck C; Godeke GJ; Lecollinet S; Bowen R; Lelli D; Nowotny N; Koopmans MPG; Reusken CBEM
    Transbound Emerg Dis; 2017 Dec; 64(6):1801-1812. PubMed ID: 27633257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological evidence for Japanese encephalitis and West Nile viruses in domestic animals of Nepal.
    Pant GR; Lunt RA; Rootes CL; Daniels PW
    Comp Immunol Microbiol Infect Dis; 2006; 29(2-3):166-75. PubMed ID: 16697904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reactivity of Japanese encephalitis virus-vaccinated horse sera in serodiagnosis of West Nile virus.
    Hirota J; Nishi H; Matsuda H; Tsunemitsu H; Shimiz S
    J Vet Med Sci; 2010 Mar; 72(3):369-72. PubMed ID: 19996564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies generated by immunization with the NS1 protein of West Nile virus confer partial protection against lethal Japanese encephalitis virus challenge.
    Sun E; Zhao J; TaoYang ; Xu Q; Qin Y; Wang W; Wei P; Wu D
    Vet Microbiol; 2013 Sep; 166(1-2):145-53. PubMed ID: 23834965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses.
    Siger L; Bowen R; Karaca K; Murray M; Jagannatha S; Echols B; Nordgren R; Minke JM
    Vet Ther; 2006; 7(3):249-56. PubMed ID: 17039448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A diagnostic algorithm to serologically differentiate West Nile virus from Japanese encephalitis virus infections and its validation in field surveillance of poultry and horses.
    Yeh JY; Lee JH; Park JY; Seo HJ; Moon JS; Cho IS; Kim HP; Yang YJ; Ahn KM; Kyung SG; Choi IS; Lee JB
    Vector Borne Zoonotic Dis; 2012 May; 12(5):372-9. PubMed ID: 22217162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.